Carlos Perdomo - Search Results

Year	Number of Results
2003	5
2004	5
2008	1
2009	2
2010	2
2011	1
2016	1
2017	1
2018	3
2019	6
2020	4
2021	5
2022	2
2023	2
2024	1

1

ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials.

Wang J, Logovinsky V, Hendrix SB, Stanworth SH, Perdomo C, Xu L, Dhadda S, Do I, Rabe M, Luthman J, Cummings J, Satlin A. Wang J, et al. Among authors: perdomo c. J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):993-9. doi: 10.1136/jnnp-2015-312383. Epub 2016 Mar 23. J Neurol Neurosurg Psychiatry. 2016. PMID: 27010616 Free PMC article. Clinical Trial.

2

Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2.

Kärppä M, Yardley J, Pinner K, Filippov G, Zammit G, Moline M, Perdomo C, Inoue Y, Ishikawa K, Kubota N. Kärppä M, et al. Among authors: perdomo c. Sleep. 2020 Sep 14;43(9):zsaa123. doi: 10.1093/sleep/zsaa123. Sleep. 2020. PMID: 32585700 Free PMC article. Clinical Trial.

3

Efficacy and safety of lemborexant in subjects previously treated with placebo for 6 months in a randomized phase 3 study.

Yardley J, Inoue Y, Pinner K, Perdomo C, Kubota N, Perlis ML, Moline M. Yardley J, et al. Among authors: perdomo c. Sleep Med. 2023 Oct;110:111-119. doi: 10.1016/j.sleep.2023.07.023. Epub 2023 Jul 27. Sleep Med. 2023. PMID: 37574610 Free article. Clinical Trial.

4

Dosing considerations for rufinamide in patients with Lennox-Gastaut syndrome: Phase III trial results and real-world clinical data.

Kothare S, Kluger G, Sachdeo R, Williams B, Olhaye O, Perdomo C, Bibbiani F. Kothare S, et al. Among authors: perdomo c. Seizure. 2017 Apr;47:25-33. doi: 10.1016/j.seizure.2017.02.008. Epub 2017 Feb 17. Seizure. 2017. PMID: 28284045 Free article. Review.

5

A global analysis of the impact of COVID-19 stay-at-home restrictions on crime.

Nivette AE, Zahnow R, Aguilar R, Ahven A, Amram S, Ariel B, Burbano MJA, Astolfi R, Baier D, Bark HM, Beijers JEH, Bergman M, Breetzke G, Concha-Eastman IA, Curtis-Ham S, Davenport R, Díaz C, Fleitas D, Gerell M, Jang KH, Kääriäinen J, Lappi-Seppälä T, Lim WS, Revilla RL, Mazerolle L, Meško G, Pereda N, Peres MFT, Poblete-Cazenave R, Rose S, Svensson R, Trajtenberg N, van der Lippe T, Veldkamp J, Perdomo CJV, Eisner MP. Nivette AE, et al. Among authors: perdomo cjv. Nat Hum Behav. 2021 Jul;5(7):868-877. doi: 10.1038/s41562-021-01139-z. Epub 2021 Jun 2. Nat Hum Behav. 2021. PMID: 34079096 Free PMC article.

6

Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials.

Whitehead A, Perdomo C, Pratt RD, Birks J, Wilcock GK, Evans JG. Whitehead A, et al. Among authors: perdomo c. Int J Geriatr Psychiatry. 2004 Jul;19(7):624-33. doi: 10.1002/gps.1133. Int J Geriatr Psychiatry. 2004. PMID: 15254918 Review.

7

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.

Bohula EA, Wiviott SD, McGuire DK, Inzucchi SE, Kuder J, Im K, Fanola CL, Qamar A, Brown C, Budaj A, Garcia-Castillo A, Gupta M, Leiter LA, Weissman NJ, White HD, Patel T, Francis B, Miao W, Perdomo C, Dhadda S, Bonaca MP, Ruff CT, Keech AC, Smith SR, Sabatine MS, Scirica BM; CAMELLIA–TIMI 61 Steering Committee and Investigators. Bohula EA, et al. Among authors: perdomo c. N Engl J Med. 2018 Sep 20;379(12):1107-1117. doi: 10.1056/NEJMoa1808721. Epub 2018 Aug 26. N Engl J Med. 2018. PMID: 30145941 Free article. Clinical Trial.

8

Impact of lemborexant treatment on insomnia severity: analyses from a 12-month study of adults with insomnia disorder.

Roth T, Rosenberg R, Morin CM, Yardley J, Pinner K, Perdomo C, Atkins N Jr, Pappadopulos E, Malhotra M, Moline M. Roth T, et al. Among authors: perdomo c. Sleep Med. 2022 Feb;90:249-257. doi: 10.1016/j.sleep.2022.01.024. Epub 2022 Feb 8. Sleep Med. 2022. PMID: 35220140 Free article. Clinical Trial.

9

Improvement in fatigue and sleep measures with the dual orexin receptor antagonist lemborexant in adults with insomnia disorder.

Chepke C, Jain R, Rosenberg R, Moline M, Yardley J, Pinner K, Kumar D, Perdomo C, Filippov G, Atkins N, Malhotra M. Chepke C, et al. Among authors: perdomo c. Postgrad Med. 2022 Apr;134(3):316-325. doi: 10.1080/00325481.2022.2049553. Epub 2022 Mar 20. Postgrad Med. 2022. PMID: 35254948

10

Long-term effectiveness and safety of lemborexant in adults with insomnia disorder: results from a phase 3 randomized clinical trial.

Yardley J, Kärppä M, Inoue Y, Pinner K, Perdomo C, Ishikawa K, Filippov G, Kubota N, Moline M. Yardley J, et al. Among authors: perdomo c. Sleep Med. 2021 Apr;80:333-342. doi: 10.1016/j.sleep.2021.01.048. Epub 2021 Feb 1. Sleep Med. 2021. PMID: 33636648 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

36 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year